Hip Replacement Market Size By Product (Primary Hip Replacement Devices, Partial Hip Replacement Devices, Revision Hip Replacement Devices, Hip Resurfacing Devices), By Material (Metal-on-plastic, Ceramic-on-plastic, Ceramic-on-ceramic), By Fixation Material (Cemented Fixation, Cementless Fixation, Hybrid Fixation), By Inserts (Cross-linked Polyethylene Inserts, Antioxidant Polyethylene Inserts, Non-antioxidant Polyethylene Inserts), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 – 2027

Industry trends

Hip Replacement Market size was estimated at over USD 6.8 billion in 2020 and is expected to grow at a CAGR of 4% from 2021 to 2027. Increasing number of road accidents and hip injuries across the world is fueling the market growth. The surge in the number of hip arthroplasty procedures is accelerating the acceptance of hip replacement devices. Furthermore, technological developments are fostering the demand for hip replacement devices.
 

Get more details on this report - Request Free Sample PDF
 

Hip replacement devices or implants are medical devices used to recover mobility and reduce pain associated with arthritis and other hip disorders. Each hip implant system has different device design features such as material, shape, fixations materials, etc. The adoption of hip replacement surgery is increasing due to its high success and low complication rate. Many hip replacements last for about 15 years, based on material, manufacturer, and types of joint replacement.
 

However, the hip replacement devices are classified as a Class III medical device that is subject to stringent regulations and compliances. As a result, these devices are regulated by the U.S. FDA. A premarket approval (PMA) is needed for class III devices before their commercial distribution. The manufacturer is required to get approval under section 515 of the act that comprises of FDA's issuance of approving the application for premarket approval (PMA) for the device. Moreover, the European Union Commission has revised medical device regulation that substitutes the current medical device directive. As per the new regulation, these devices are classified as class 3 devices that refer to a class of high-risk devices that are subject to stringent compliances. Hence, stringent regulations will impede the industry growth during the forecast period.
 

The ongoing COVID-19 pandemic is an unprecedented public health concern. This pandemic has adversely impacted the number of hip arthroplasty procedures. High risk of COVID-19 infection involved during the surgical procedure along with rising COVID-19 patient admissions in the hospitals are one of the prime factors resulting in declining surgical procedures. For instance, in the UK, about 100,000 joint replacement surgeries were cancelled during the first wave of COVID-19 in the early 2020. Although, the industry is poised to witness significant growth due to the decreasing number of COVID-19 patients in some regions and implementation of standard operating protocols in healthcare facilities. The government initiatives for providing clinical emergency care to patients suffering from osteoarthritis have sustained the revenue growth.
 

Get more details on this report - Request Free Sample PDF
 

Rising geriatric population coupled with growing prevalence of hip arthritis and osteoporosis is anticipated to boost the hip replacement market expansion

Increasing prevalence of hip arthritis and osteoporosis along with the growing geriatric population will promote the market progression. The recent and ongoing technological advancements have resulted in young teenagers with juvenile arthritis and elderly people successfully treated with hip replacements. Hence, device manufacturers are emphasizing more on hip implant design to mimic the natural movement of the body.
 

Growing acceptance of primary hip replacement devices will fuel the market revenue

The primary hip replacement devices segment accounted for USD 4.98 billion in 2020. The benefits offered by primary hip replacement procedures include improved function, pain relief, and advanced quality of life among others resulting in augmenting the segment revenue in the coming years. Additionally, manufacturers in the market offer a comprehensive portfolio of technologically advanced hip products coupled with a focus on specific requirements of individual patients. The high growth rate of the segment is owing to developments in hip joint replacement surgical methods that reduce the risk of chronic health conditions and allow the removal of the diseased bone & cartilage. The rising usage of hip replacement devices is due to the high success rate of primary hip reconstruction surgery.
 

Increasing preference for metal-on-plastic hip replacement devices will positively impact the industry expansion

The metal-on-plastic segment in the hip replacement market exceeded USD 3.81 billion in 2020 led by the advantages metal-on-plastic devices offer that include durability, reliable outcome, affordable alternative, etc. Metal-on-plastic hip replacement devices are a good option for less active patients and are the most commonly used hip reconstruction implants. Several other benefits such as technological advancements, fewer complications, and lesser wear particles are increasing its adoption.  The most commonly used metal and plastic include stainless steel & titanium and polyethylene, respectively. It is the widely used artificial hip component material chosen by surgeons owing to its advantages.
 

Benefits of cemented fixation in high survival rate of implant will spur the hip replacement market demand

Get more details on this report - Request Free Sample PDF

The cemented fixation segment is projected to expand at 1.8% growth rate to reach USD 751 million by 2027 due to benefits such as high survival rate, forms an interlocking fit between implant & bone, and allows the bone to grow onto the implant over time. For instance, the survival rate of cemented fixation used at 10 years is around 96% in patients aged over 75 years. Cemented fixation uses fast-drying bone cement to attach the patient's natural bone and the prosthetic joint component. A small amount of antibiotic material can be added to the bone as the cement dries within 10 minutes of application thus, helps to reduce the risk of post-surgical infection.
 

High acceptance of cross-linked polyethylene inserts in hip arthroplasty will positively affect the industry revenue

The hip replacement market for cross-linked polyethylene inserts segment is predicted to attain a CAGR of 2.4% to cross USD 3.3 billion by 2027 on account of the advantages of cross-linked polyethylene include reduced osteolysis, offers excellent clinical outcomes, and implant survivorship among others. These inserts are developed precisely to decrease polyethylene wear and subsequent wear debris-induced osteolysis. For instance, clinical studies have demonstrated that cross-linked polyethylene inserts have a high success rate in primary hip arthroplasty. Moreover, in hip reconstruction procedures, this insert is comparatively insensitive to femoral head size, allows the surgeon to use large femoral heads to strengthen hip stability and decrease post-operative complications.
 

Increasing hospitalizations with severe hip arthritis and osteoporosis will simulate the industry value

The hospitals segment dominated more than 84% of the hip replacement market share in 2020. High usage of advanced hip replacement devices providing improved outcomes will drive the patient preference for hospitals. Growing hospital admissions with several hip disorders along with the availability of trained healthcare professionals will impel the demand for hip reconstruction devices in the hospitals. Furthermore, hospitals provide continuous monitoring after surgery, design exercise to restore strength, work closely with patients, and offer physical therapies. Therefore, patient preference for a well-equipped emergency orthopedic surgery department will fuel the segment demand. As a result, well-equipped hospitals will be preferred by the patients. The rising patient inflow has further increased the product adoption rate, thereby fostering the market growth in the coming years.
 

Growing incidences of road accidents in North America will stimulate the regional growth

Get more details on this report - Request Free Sample PDF

U.S. dominated the North America hip replacement market and accounted for over USD 3.23 billion in 2020, propelled by several factors including favourable reimbursement scenario, growing adoption of orthopedic surgeries, and rising burden of hip related ailments in the country. According to the Agency for Healthcare Research and Quality, over 450,000 primary hip replacements are performed every year in the U.S. Hip injuries as a result of road accidents and falls are a common cause of hip dislocation and require hip reconstruction.
 

Germany held the largest revenue share in the Europe market and was valued at USD 366 million in 2020, driven by increasing healthcare expenditure and increasing efforts taken to prevent important health risk factors. Germany accounts for the highest healthcare expenditure in Europe.
 

Prominent industry players are extensively focusing on product innovation and strategic collaborations to sustain their competitive advantage

Some of the leading companies operating in the market include Stryker, Zimmer Biomet, Johnson and Johnson, Smith & Nephew, MicroPort Orthopedics Inc., LimaCorporate, DJO Global Inc., and Waldemar Link GmbH & Co. KG among others. These industry leaders are implementing several organic as well as inorganic growth strategies in order to attain competitive advantage over the competitors and strengthen their market position.
 

Some of the recent industry developments:

• In March 2018, Stryker Corporation announced the launch of the Trident II Acetabular System. This device is used in primary and revision patients at high risk of hip dislocation owing to several hip ailments. This product launch expanded the company’s product portfolio, thereby strengthening its position in the market.
   
• In March 2017, DJO Medical Inc. received the U.S. FDA approval for its Exprt Revision Hip portfolio. This portfolio was launched with improved designs and focus on patient outcomes. This move expanded the company's customer base and assisted in accelerating the company's revenue.
   

The hip replacement market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and volume in Units from 2016 to 2027 for the following segments:

Market, By Product, 2016 - 2027 (USD Million and Units)

• Primary Hip Replacement Devices
• Partial Hip Replacement Devices
• Revision Hip Replacement Devices
• Hip Resurfacing Devices

Market, By Material, 2016 - 2027 (USD Million and Units)???????

• Metal-on-plastic
• Ceramic-on-plastic
• Ceramic-on-ceramic
• Others

Market, By Fixation Material, 2016 - 2027 (USD Million and Units)

• Cemented Fixation
• Cementless Fixation
• Hybrid Fixation

Market, By Inserts, 2016 - 2027 (USD Million and Units)

• Cross-linked Polyethylene Inserts
• Antioxidant Polyethylene Inserts
• Non-antioxidant Polyethylene Inserts

Market, By End-use, 2016 - 2027 (USD Million and Units)

• Hospitals

• Ambulatory Surgical Centers

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE